IMARC Group, a leading market research company, has recently releases report titled “Clinical Data Analytics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global clinical data analytics market trends, share, size, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the Clinical Data Analytics Market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 14.7 Billion |
| Market Forecast in 2028 | US$ 93.8 Billion |
| Growth rate (2023 to 2028) | CAGR of 35.4% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is a Clinical Data Analytics?
Clinical Data Analytics is an intricate process that involves the application of insights from statistical data, pattern analysis, and insightful mining of data derived from clinical operations and administrative, financial, and patient-centered health data. This process provides a framework to improve the quality of patient care, manage population health, reduce healthcare costs, and enhance patient satisfaction. Clinical data analytics helps healthcare providers to make informed decisions, evaluate patient outcomes, and create personalized treatment plans based on an individual’s health history and current conditions.
Get a Sample Copy of Report at: https://www.imarcgroup.com/clinical-data-analytics-market/requestsample
What are the growth prospects and trends in the Clinical Data Analytics industry?
The expanding adoption of electronic health records (EHRs) represents the prime factor fuelling the adoption of clinical data analytics to facilitate the early detection of diseases, enhance patient safety, and improve the quality of healthcare services. In addition to this, the increasing emphasis on value-based care is encouraging a surging number of healthcare organizations to adopt clinical data analytics for efficient patient management, cost control, and improved health outcomes. Moreover, the rising need for personalized and precision medicine is contributing to the market’s growth as data analysis helps in identifying individual health risks and outcomes. Furthermore, ongoing technological advancements such as the integration of artificial intelligence (AI) and machine learning (ML) technologies to enhance data analytics capabilities, improve predictive analysis, and help clinicians make more accurate decisions are presenting remunerative opportunities for the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Solution:
- Software
- Services
Breakup by Deployment Mode:
- Cloud-based
- On-premises
Breakup by Application:
- Quality Improvement and Clinical Benchmarking
- Clinical Decision Support
- Regulatory Reporting and Compliance
- Comparative Analytics
- Precision Health
Breakup by End User:
- Pharmaceutical Companies
- Healthcare Organizations
- Research Organizations
- Government Organizations
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Allscripts Healthcare Solutions Inc
- CareEvolution LLC
- Cerner Corporation
- Health Catalyst
- International Business Machines Corporation
- InterSystems Corporation
- Koninklijke Philips N.V
- Medeanalytics Inc.
- Sisense Inc.
- UnitedHealth Group Incorporated
- Xerox Holdings Corporation.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
